Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Mesothelioma × Zoledronic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Prostatic Neoplasms 11 Breast Neoplasms 9 Neoplasm Metastasis 6 Multiple Myeloma 5 Osteoporosis 4 Carcinoma, Renal Cell 3 Carcinoma, Non-Small-Cell Lung 3 Ovarian Neoplasms 2 Lung Neoplasms 2 Kidney Neoplasms 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Small Cell Lung Carcinoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Osteonecrosis 1 Oligodendroglioma 1 Neovascularization, Pathologic 1 Neoplasms, Plasma Cell 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm, Residual 1 Neoplasm Micrometastasis 1 Nasopharyngeal Neoplasms 1 Myelodysplastic Syndromes 1 Mesothelioma 1 Lymphoma 1 Leukemia 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Gliosarcoma 1

Interventions

Pemetrexed 9 Gemcitabine 8 Cisplatin 7 Nivolumab 4 durvalumab 3 Vinorelbine 3 Ipilimumab 3 Carboplatin 3 Bevacizumab 3 tremelimumab 2 pembrolizumab 2 olaparib 2 niraparib 2 anetumab ravtansine 2 Imatinib Mesylate 2 Fluorodeoxyglucose F18 2 vandetanib 1 tazemetostat 1 sargramostim 1 ribociclib 1 fludarabine phosphate 1 fludarabine 1 defactinib 1 decitabine and cedazuridine drug combination 1 bintrafusp alfa protein, human 1 Zoledronic Acid 1 Vitamin B 12 1 Valproic Acid 1 UV1 vaccine 1 TroVax 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01204203 2017-05-24

UAB0901

University of Alabama at Birmingham

Phase 2 Completed

8 enrolled 5 charts

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡